Literature DB >> 6350115

Effect of acarbose, pectin, a combination of acarbose with pectin, and placebo on postprandial reactive hypoglycaemia after gastric surgery.

P A Speth, J B Jansen, C B Lamers.   

Abstract

In a double-blind study we have compared the effect of 50 mg acarbose, 100 mg acarbose, 4.2 g pectin, a combination of 50 mg acarbose with 4.2 g pectin, and placebo on plasma glucose, plasma insulin, breath hydrogen and hypoglycaemic symptoms after a normal carbohydrate rich meal in nine patients with previous gastric surgery. Fifty milligrams acarbose, 100 mg acarbose and the combination of 50 mg acarbose with 4.2 g pectin significantly inhibited the postprandial peak glucose concentration (p less than 0.01). The lowest plasma glucose concentration, observed 60-150 minutes after ingestion of the meal, was significantly increased by the addition of 50 mg acarbose (p less than 0.01) and the combination of acarbose with pectin (p less than 0.05). The combination of acarbose with pectin was the only treatment that significantly inhibited the plasma insulin peak (p less than 0.05). Eight of nine patients had symptoms of hypoglycaemia on placebo, two on 50 mg acarbose (p less than 0.05), two on 100 mg acarbose (p less than 0.05), five on pectin (ns), and two on the combination of acarbose and pectin (p less than 0.05). All treatments with acarbose induced significant increases in breath hydrogen excretion (p less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6350115      PMCID: PMC1420095          DOI: 10.1136/gut.24.9.798

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  The late postprandial dumping syndrome.

Authors:  E R Woodward; C L Neustein
Journal:  Major Probl Clin Surg       Date:  1976

2.  Effect of dietary fiber on complications of gastric surgery: prevention of postprandial hypoglycemia by pectin.

Authors:  D J Jenkins; M A Gassull; A R Leeds; G Metz; J B Dilawari; B Slavin; L M Blendis
Journal:  Gastroenterology       Date:  1977-08       Impact factor: 22.682

3.  Combined use of guar and acarbose in reduction of postprandial glycaemia.

Authors:  D J Jenkins; R H Taylor; R Nineham; D V Goff; S R Bloom; D Sarson; K G Alberti
Journal:  Lancet       Date:  1979-11-03       Impact factor: 79.321

4.  A glycoside-hydrolase inhibitor in treatment of dumping syndrome.

Authors:  J C McLoughlin; K D Buchanan; M J Alam
Journal:  Lancet       Date:  1979-09-22       Impact factor: 79.321

5.  Decrease in postprandial insulin and glucose concentrations by guar and pectin.

Authors:  D J Jenkins; A R Leeds; M A Gassull; B Cochet; G M Alberti
Journal:  Ann Intern Med       Date:  1977-01       Impact factor: 25.391

6.  Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity.

Authors:  D J Jenkins; T M Wolever; A R Leeds; M A Gassull; P Haisman; J Dilawari; D V Goff; G L Metz; K G Alberti
Journal:  Br Med J       Date:  1978-05-27

7.  A simple method of measuring breath hydrogen in carbohydrate malabsorption by end-expiratory sampling.

Authors:  G Metz; M A Gassull; A R Leeds; L M Blendis; D J Jenkins
Journal:  Clin Sci Mol Med       Date:  1976-03

8.  Effect of gel fibre on gastric emptying and absorption of glucose and paracetamol.

Authors:  S Holt; R C Heading; D C Carter; L F Prescott; P Tothill
Journal:  Lancet       Date:  1979-03-24       Impact factor: 79.321

9.  Sucrose malabsorption in man after ingestion of alpha-glucosidehydrolase inhibitor.

Authors:  W F Caspary
Journal:  Lancet       Date:  1978-06-10       Impact factor: 79.321

10.  Unabsorbable carbohydrates and diabetes: Decreased post-prandial hyperglycaemia.

Authors:  D J Jenkins; D V Goff; A R Leeds; K G Alberti; T M Wolever; M A Gassull; T D Hockaday
Journal:  Lancet       Date:  1976-07-24       Impact factor: 79.321

View more
  8 in total

1.  Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man.

Authors:  L O Uttenthal; O O Ukponmwan; M Ghiglione; S R Bloom
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

2.  Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995.

Authors:  W P Hopman; R G Wolberink; C B Lamers; J H Van Tongeren
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

3.  Long-term treatment with acarbose for the treatment of reactive hypoglycemia.

Authors:  A G Ozgen; F Hamulu; F Bayraktar; S Cetínkalp; C Yilmaz; M Túzún; T Kabalak
Journal:  Eat Weight Disord       Date:  1998-09       Impact factor: 4.652

Review 4.  Medical nutrition therapy for post-bariatric hypoglycemia: practical insights.

Authors:  Emmy Suhl; Sue-Ellen Anderson-Haynes; Christopher Mulla; Mary-Elizabeth Patti
Journal:  Surg Obes Relat Dis       Date:  2017-01-16       Impact factor: 4.734

Review 5.  Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  S P Clissold; C Edwards
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 6.  Octreotide, a long-acting somatostatin analog, in the management of postoperative dumping syndrome. An update.

Authors:  C B Lamers; A M Bijlstra; A G Harris
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

Review 7.  Digital Solutions to Diagnose and Manage Postbariatric Hypoglycemia.

Authors:  Katja A Schönenberger; Luca Cossu; Francesco Prendin; Giacomo Cappon; Jing Wu; Klaus L Fuchs; Simon Mayer; David Herzig; Andrea Facchinetti; Lia Bally
Journal:  Front Nutr       Date:  2022-04-07

Review 8.  International consensus on the diagnosis and management of dumping syndrome.

Authors:  Emidio Scarpellini; Joris Arts; George Karamanolis; Anna Laurenius; Walter Siquini; Hidekazu Suzuki; Andrew Ukleja; Andre Van Beek; Tim Vanuytsel; Serhat Bor; Eugene Ceppa; Carlo Di Lorenzo; Marloes Emous; Heinz Hammer; Per Hellström; Martine Laville; Lars Lundell; Ad Masclee; Patrick Ritz; Jan Tack
Journal:  Nat Rev Endocrinol       Date:  2020-05-26       Impact factor: 43.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.